UK markets closed
NIKKEI 225
38,405.66 +470.90 (+1.24%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.55 -1.08 (-1.31%) GOLD FUTURES
2,297.30 -60.40 (-2.56%) DOW
37,815.92 -570.17 (-1.49%) Bitcoin GBP
48,208.29 -2,186.81 (-4.34%)
MRK Dec 2025 90.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:22AM EDT. Market open.
| Previous close | 41.72 |
| Open | 41.72 |
| Bid | 43.35 |
| Ask | 44.50 |
| Strike | 90.00 |
| Expiry date | 2025-12-19 |
| Day's range | 41.72 - 41.72 |
| Contract range | N/A |
| Volume | |
| Open interest | 99 |
Insider MonkeyMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript April 25, 2024 Merck & Co., Inc. beats earnings expectations. Reported EPS is $2.07, expectations were $1.94. Merck & Co., Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank […]
Business WireMerck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults
RAHWAY, N.J., April 29, 2024--Merck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults
Simply Wall St.Merck & Co., Inc. (NYSE:MRK) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Merck & Co., Inc. ( NYSE:MRK ) just released its quarterly report and things are looking bullish. The company beat...
© 2024 Yahoo. All rights reserved.